MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
335.52%
Quick Ratio
335.52%
Cash Ratio
294.90%
Debt to Asset Ratio
501.65%
Unit: Dollar
Assets Breakdown
    • Cash and cash equivalents
    • Prepaid expenses and other asset...
    • Operating lease right-of-use ass...
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Deferred revenue
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
515,758
1,290,978
2,375,493
2,976,658
Prepaid expenses and other assets
71,048
84,975
71,507
87,428
Total current assets
586,806
1,375,953
2,447,000
3,064,086
Operating lease right-of-use assets
50,384
57,410
64,307
71,081
Total assets
637,190
1,433,363
2,511,307
3,135,167
Accounts payable
139,052
319,803
51,521
19,646
Accrued expenses and other liabilities
9,580
33,536
690,085
40,432
Current portion of operating lease obligations
26,262
28,981
24,724
27,455
Total current liabilities
174,894
382,320
766,330
87,533
Deferred revenue
3,000,000
3,000,000
3,000,000
3,000,000
Operating lease obligations, less current portion
21,566
29,380
36,889
44,181
Total liabilities
3,196,460
3,411,700
3,803,219
3,131,714
Preferred stock, value-Series APreferred Stock
-
-
-
0
Preferred stock, value-Series BConvertible Preferred Stock
-
-
-
0
Preferred stock, value-Undesignated Preferred Stock
-
-
-
0
Common stock, 0.0001 par value 500,000,000 shares authorized 173,791,968 and 172,573,545 shares issued and outstanding at june 30, 2026 and december 31, 2025
17,379
17,257
17,257
17,257
Additional paid-in capital
54,143,303
54,110,425
54,110,425
54,110,425
Accumulated deficit
-56,719,952
-56,106,019
-55,419,594
-54,124,229
Total stockholders deficit
-2,559,270
-1,978,337
-1,291,912
3,453
Total liabilities and stockholders deficit
637,190
1,433,363
2,511,307
3,135,167
Unit: Dollar. Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$515,758 (-86.20%↓ Y/Y)Prepaid expenses andother assets$71,048 (-22.79%↓ Y/Y)Total current assets$586,806 (-84.68%↓ Y/Y)Operating leaseright-of-use assets$50,384 (-35.18%↓ Y/Y)Total assets$637,190 (-83.69%↓ Y/Y)Accumulated deficit-$56,719,952 (-6.19%↓ Y/Y)Total liabilities andstockholders deficit$637,190 (-83.69%↓ Y/Y)Total stockholdersdeficit-$2,559,270 (-457.62%↓ Y/Y)Additional paid-in capital$54,143,303 (0.06%↑ Y/Y)Common stock, 0.0001par value...$17,379 (0.71%↑ Y/Y)Total liabilities$3,196,460 (0.14%↑ Y/Y)Deferred revenue$3,000,000 (0.00%↑ Y/Y)Total currentliabilities$174,894 (24.96%↑ Y/Y)Operating leaseobligations, less current...$21,566 (-58.58%↓ Y/Y)Accounts payable$139,052 (30.87%↑ Y/Y)Current portion ofoperating lease...$26,262 (1.06%↑ Y/Y)Accrued expenses andother liabilities$9,580 (24.01%↑ Y/Y)

Inhibitor Therapeutics, Inc. (INTI)

Inhibitor Therapeutics, Inc. (INTI)